Why the SEC Should be More Like the FDA

Why the SEC Should be More Like the FDA

 

 

The FDA and the SEC hypothetically play the same role in our lives: to protect us from products that could harm us.

 If you’re selling a new drug, you can't escape the strict oversight of the FDA. But if you’re selling a new investment product, you’ll have a much easier time getting it past the SEC. Prescription drugs must be safe and effective, but there is no law stating that investment products have to be effective. Or even that they have to be safe.

 Why is that?

 Imagine the FDA shrugging their shoulders after an unsafe drug caused death or injury to innocent people. Suppose the FDA said something similar to what we hear all the time from Wall Street:

 "You should have done your research. We told you there was risk involved."

 The public would be outraged—and rightfully so.

 The FDA requires 12 steps to drug approval. Most drug products can’t pass the first three. If they do, they face three more trials. It can take years to get a safe, effective drug to market. But given the consequences of a poorly vetted drug, few of us would advocate eliminating steps to speed the trial process along.

The SEC, on the other hand, is under constant political pressure to shorten and eliminate their approval processes.

 To further protect consumers, the FDA recalls approved drugs that are later found to be harmful to get them off the market (remember Fen-Phen?). The SEC can't—or won't—follow suit. They made virtually no effort to prosecute even the worst actors for their roles in the credit crisis of 2008. Further, they failed to pursue Bernie Madoff even though they had been informed of his scam long before he confessed. 

The ultimate victim of the SEC’s inadequate oversight is the investor. Too many financial products, promising too much, come to market every day. Investors deserve to be protected by an SEC that takes our financial health as seriously as the FDA takes our physical health.

Ax Jackiniel Ekressin

étudiant(e) (Pigier)

9 年

Salut mr! Moi Ekressin j'aimerais postulé dans votre entreprise !!!!

回复
Lawrence S.

Drive Your Dreams

9 年

Bruno since you feel that China and a communist government does a better job than western countries, may be you should migrate to China and open your business there. Insulting western world as arrogant and blind is not a way to attract their investment capital. It's not necessarily the government's job to invest in businesses. Keep in mind your business is unproven there for an investor to invest they are speculating. Besides LinkedIn is not the place to find investors. A business must, crawl, walk then run. This is the way investors judge businesses, unless you have at least a couple successful exits like Elon Musk. Elliot makes very valid points and bad investment registered or not registered at the SEC can take someone's life savings by bad actors. That can lead to being homeless, penniless and even in some cases suicide. Not all investors are accredited, many are unsuspecting average person who might sink their whole life savings of $100,000 into a business. Many people will even borrow money to invest, being left in debt. On the other side, to get a FDA drug approved can take years and if it tooks years to get an investment approved, that you kill the ability of start-ups to raise capital.

On 01-18-2011, I walked away from a dream corporate career to pursue my passion of adding value to lives worldwide. Followed with a price tag of loosing my home, cars, & all finances. It's never been about the money; genuine intent is to help others. The funds awarded me will be controlled by the best in the financial industry. "IT'S ALL GOOD" Love, Michael

回复

要查看或添加评论,请登录

Elliot S. Weissbluth的更多文章

  • Inspiring Discussions at the Crossroads of Health and Wealth: Apex 2017

    Inspiring Discussions at the Crossroads of Health and Wealth: Apex 2017

    At HighTower, we are firm believers that financial success is not an end-goal in and of itself, but rather a catalyst…

    4 条评论
  • The Three Places I Go to Focus

    The Three Places I Go to Focus

    Escaping from distraction is critical—and increasingly difficult in our hyper-connected world. In a recent post for…

    8 条评论
  • A Transformational Transaction: HighTower Acquires WealthTrust

    A Transformational Transaction: HighTower Acquires WealthTrust

    We are very proud to welcome WealthTrust to the HighTower community. The transaction is the largest in HighTower’s…

  • The Smart Stranger, Part 2: The Power of Outsiders

    The Smart Stranger, Part 2: The Power of Outsiders

    “What can the story of an outsider tell us about spurring innovation?” asks this New York Times video, featuring…

    18 条评论
  • Walking backward from the future

    Walking backward from the future

    In this series, professionals discuss their experiences accomplishing something for the first time. Read their stories…

    5 条评论
  • The Profitability Milestone

    The Profitability Milestone

    For the first few years at HighTower, every month I would dread the call with my CFO to see how much money we lost that…

    15 条评论
  • An #OpenLetter to Executives Who Think Business is Like Sports

    An #OpenLetter to Executives Who Think Business is Like Sports

    Dear fellow CEOs, Business is not a game. We’ve said it before.

    61 条评论
  • The Big Letdown…and the Big Break

    The Big Letdown…and the Big Break

    During HighTower’s startup days, while frantically raising capital to launch, we ran around New York in back-to-back…

    10 条评论
  • Do The Scary Stuff

    Do The Scary Stuff

    “Do the uncomfortable.” This advice came from my mentor at my first “career” job—the man who taught me to be a lawyer.

    15 条评论
  • #MyIdealWorkplace: The Crossroads of Achievement and Fulfillment

    #MyIdealWorkplace: The Crossroads of Achievement and Fulfillment

    My friend Tony Robbins says, “Success without fulfillment is the ultimate failure.” That to live an extraordinary life,…

    37 条评论

社区洞察